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CHAPTER 1.  REVIEW OF LITERATURE 
Introduction 
The Porcine Reproductive and Respiratory Virus (PRRSV, PRRS) is a 
problematic virus not only for pork producers but for the diagnostic labs that serve 
them.  Detection of the virus by real-time reverse-transcriptase polymerase chain-
reaction (real-time RT-PCR) has become widely used because of this assay’s 
improved sensitivity and turnaround time compared to virus isolation.  The purpose 
of this review is to evaluate the risk of missed PRRSV detection by real-time RT-
PCR, with specific emphasis on a new sample type, swine oral fluids.  The primary 
contributors to false-negative results include: virus mutation, viral degradation in 
clinical samples, and compounds that undermine the real-time reverse-transcriptase 
polymerase chain-reaction (real-time RT-PCR) chemistry, collectively known as 
‘PCR inhibitors’.   
Importance of oral fluids as a diagnostic tool for animal health 
A wide range of immune defense processes take place via the salivary 
proteins.37  Advances in basic research of this sample type were gained during 
progression of human diagnostic testing for Human Immunodeficiency Virus (HIV).43 
Interestingly, HIV detection in oral fluid in combination with markers of disease also 
found in oral fluid, such as beta-2 microglobulins and/or tumor necrosis factor, were 
used together to monitor AIDS-disease status of patients.37   As another example, 
detection of Helicobacter bacterial DNA from human oral fluid in combination with 
clinical signs has been used to identify infection in its clinically active state.37     
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There have been numerous reports of oral fluids in veterinary diagnostic roles 
in cats, dogs, cattle, and pigs.43   Collection of swine oral fluids has proven to be 
easy as pigs naturally investigate and chew on new objects within their pen.41 
Samples are collected by hanging cotton rope shoulder-height in a clean area of the 
pen, allowing pigs 30 minutes to deposit oral fluid by chewing on the rope.  Oral 
fluids are then extracted from the rope by squeezing the rope into a collection bag.  
Collection of this sample has the further advantage of maintaining biosecurity as it 
can be taken by resident barn personnel.46   Modification of a commercially available 
PRRS ELISA has enabled its use in post-exposure measurement of PRRS 
antibody.26 Sampling of a large number of animals and testing for a wide range of 
infectious agents is predicted to enable more efficient surveillance in the swine 
industry.46  
The polymerase chain-reaction has rapidly become the preferred method of 
virus detection for food-animal production systems where timely results are needed.  
Specifically, fluorescence-based real-time RT-PCR has been transformed from an 
experimental technology into a mainstream scientific tool for detection of viral (and 
other) RNA.  Qualitative detection (positive / negative) of viral RNA is possible as 
well as relative quantification of the level of virus in the sample; however, the 
sensitivity of detection and accuracy of quantification is dependent on many factors.  
Important issues such as sample collection, transport, sample processing, assay 
optimization, analysis and  interpretation are important and sometimes overlooked.8  
Specifically for PRRS, current commercially available real-time RT-PCR reagents 
(LifeTechnologies, Inc. TaqMan NA and EU PRRSV reagents and Tetracore, Inc. 
3 
 
VetAlert NA and EU PRRSV PCR reagents) incorporate multiple primer and probes 
multiplexed to enable robust detection of variant PRRSV field strains.20  This design 
allows amplification of the same template in multiple regions of the viral RNA, 
making its application as a PRRS quantification tool questionable compared to 
traditional single-target assay designs.   
Until recently, swine serum has been the specimen type of choice for PRRS 
virus detection by real-time RT-PCR.  Although serum remains the gold-standard, 
oral fluid has gained attention as a valuable alternative.40-43,46    Under experimental 
conditions, pigs inoculated with PRRSV were shown to contain diagnostic levels of 
virus approximately four weeks after exposure enabling monitoring of disease by 
sampling in two to four week intervals.41  A study in three commercial swine 
operations reported 77% agreement of PRRS  real-time PRRS RT-PCR between 
serum and oral fluid samples.40  Although oral fluid was slightly less sensitive in this 
study, a larger proportion of animals per pen is represented and more pen samples 
can be taken for the same cost making the overall approach preferable over serum 
collection. 
Background  
Under-appreciated role of PCR inhibition  
While much work has focused on the strategic use of oral fluid for PRRSV 
detection, one aspect that may not be fully appreciated is the potential of this sample 
matrix to inhibit PCR reactions.  PCR is an enzymatic reaction and therefore 
sensitive to inhibitors.30,50  In a chapter on the subject in a recent PCR 
troubleshooting book, Gallup notes,  
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“One of the least acknowledged problems with PCR, RT-PCR and qPCR is 
reaction inhibition.”19    
PCR inhibition often involves factors from the sample itself which interfere 
with or are not removed during the nucleic acid extraction process causing the final 
PCR assay to fall short of its potential of detection and quantification of its target.  
Prior to any other assay improvement, inhibition must be eliminated or the resulting 
cycle quantity (Cq, otherwise known as cycle threshold, Ct – the cycle at which a 
sample’s fluorescent signal crosses an established threshold due to logorhthmic 
amplification) will not be proportional to the amount of template in the sample.19  One 
technique to limit inhibition is to dilute the template. Gallup suggests the ‘CRUD’ 
rule:  “Cq values are only Reliable in Uninhibited qPCR reactions wherein high-
quality samples and standards have undergone premeditatedly precise, dynamically 
sound Dilutions.”19 Known as the “sample effect”19, each sample type (i.e. spleen, 
lung, serum, feces, oral fluid) has unique endogenous inhibitors.   
“Only after crud is not allowed to interfere with the RT and PCR reactions can 
we accept the entire process to be capable of yielding quantitatively 
informative or biologically relevant information,”19 says Gallup.   
The exact sources of PCR inhibition within swine oral fluid have not been fully 
defined but neutralization and/or elimination of these sources remain an important 
step in the development of efficient pre-PCR treatment.17 
Swine oral fluid PCR inhibition demonstrated 
Initially, detection of PRRSV in swine oral fluid by PCR was found to be 
inadequately sensitive using methods designed for serum.  Stensland and Kim of the 
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Iowa State University Veterinary Diagnostic Lab (ISUVDL) developed a modified 
method optimizing sample lysis buffer and more vigorous agitation of samples during 
lysis [unpublished data].  In a later study, evaluation of internal controls showed that 
4.6% (2/43) of internal controls still failed using this method (method A1, magnetic 
bead-based, viral RNA extraction kit with modified lysis buffer and increased lysis 
step intensity).10   These potential false-negatives were significantly reduced when 
the enzyme mix (taq polymerase and reverse-transcriptase mixture) concentration 
was optimized by, in this case, doubling the quantity of enzyme in the mastermix.    
The method that had the best sensitivity in this study involved increasing 
sample input volume along with larger volumes of RNA purification reagents in the 
extraction process (method A2).   Interestingly, sensitivity improvement using the 
larger-volume extraction method was only revealed after increasing the enzyme 
concentration in the PCR reaction.   
In summary, large-volume extraction followed by increased PCR enzyme 
concentration in the reaction resulted in a significant improvement in detection of 
PRRSV, eliminated failed internal controls (in study samples), and significantly 
reduced variation of internal controls in the study samples.10  This observation is 
consistent with reports that inhibition of Taq and RT enzymes used in PCR is the 
most common cause of overall PCR inhibition.57    
The best PRRS PCR extraction and PCR method from this study10 was 
implemented in routine diagnostic testing of swine oral fluid submissions received at 
the Boehringer Ingelheim Health Management Center Diagnostic Lab.  Serum 
samples were tested using extraction and PCR methods as described elsewhere.20 
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The distribution of Cq values from real-time PRRS PCR positive oral fluid and serum 
field samples from the same time period is presented in Figure 1.  Differences in Cq 
data between specimen types is shown to highlight differences in PRRS virus 
detection and concentration between these two sample types as they are currently 
tested, discussed further in following sections. 
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Figure 1:  PRRS real-time PCR Cq distribution from RT-PCR-positive oral 
fluid and serum diagnostic samples tested between September 1, 2011 and 
August 31st 2012 at the Boehringer Ingelheim Vetmedica Health Management 
Center Diagnostic Lab. 
 
 Oral Fluid Serum 
Number of Positive Samples (n) 2381 4854 
Mean Cq 32.1 28.1 
Minimum Cq Observed 18.7 11.8 
Maximum Cq Observed 38 (assay cutoff) 38 (assay cutoff) 
Percent (failed/total) of Failed Internal 
Controls among All Samples Tested 
1.7% (124/7205) 0.2% (48/24030) 
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Challenges to PRRSV RT-PCR diagnostic sensitivity  
Primer/probe miss-matches to mutating virus 
 
Although RT-PCR is theoretically sensitive enough to detect one PRRS virion 
in a sample under ideal conditions, a number of factors may prevent this from 
occurring in the dynamic situation faced by diagnostic laboratories and veterinarians 
chasing ever-changing field strains.  As a single-stranded, positive-sense RNA virus 
with a 15kb genome, PRRS mutates at a relatively high rate as it is transmitted from 
pig to pig over time.33    RNA viruses are inherently more prone  to mutation, due in 
part to the infidelity of the RNA polymerase it uses to replicate.   The calculated rate 
of PRRSV nucleotide substitution is the highest reported so far for an RNA virus, 
estimated as 4.7-9.8 x 10-2 / nucleic acid site / year.33 
Detection of virus in clinical samples by real-time RT-PCR works best when 
the viral RNA target is conserved and stable. Hydrolysis probe (Taq-Man®) real-time 
PCR chemistry functions by  making copies of a specific amplicon  as a result of 
primers binding to the target, followed by fluorescent signal generation if the 
amplicon-specific probe hybridizes to its complimentary target.9  Current commercial 
PCR assays (Tetracore Inc. and Life Technologies)  for the mutating PRRS virus 
utilize multiple primers and probes  in a multiplexed PCR assay format as a strategy 
to ensure adequate detection.20  In spite of this strategy, in a recent study PRRSV 
was missed in 6% (27 of 423) of the diagnostic cases evaluated (of multiple different 
sample types including lung, serum, oral fluids, and others) when reliance was 
placed on a single real-time PRRS PCR test alone.20   
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The effect of sample pooling 
Pooling of samples, a common practice, is a significant risk factor in missed 
detection20, and has previously been proven to reduce sensitivity.49  In serum and 
blood swab samples, pooling 1:3 and 1:5 decreased sensitivity over the course of 
the study by 6% and 8% respectively with an even more pronounced effect within 
the first five days post-infection, with up to 14% missed-detection in pooled 
samples.49  As shown in figure 1, serum diagnostic samples contain lower Cq values 
(and thereby higher concentration of virus) than oral fluid samples.  It would be 
expected, based on concentration alone, that pooling of oral fluid samples may 
present an even higher risk of missed detection by overly diluting the target beyond 
the detection limits of the test. 
Sample integrity / degradation 
RNA is universally understood to be sensitive to degradation due to many 
contributing factors  even in controlled conditions.34  An assay for measuring mRNA 
has been developed to determine if degradation of target RNA occurred within a 
sample rendering it unsuitable for testing.34  Viral RNA was tested alongside mRNA 
and it was concluded that viral RNA degradation contributes to false-negative PCR 
reactions.34  Bustin refers to DNA as “tough as old boots” and RNA as extremely 
delicate once removed from the environment.8  Detection of RNA viruses from oral 
fluids has been noted as more complicated because single-stranded RNA is much 
less stable than double-stranded DNA, in this specimen type37  leading to 
degradation prior to testing.  Despite of the labile nature of pure RNA, viral RNA 
within an intact PRRS virion is expected to be more stable according to two studies 
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completed on the subject.24,42  The issue of PRRS virus stability in swine oral fluids is 
important due to the relatively lower viral load of swine oral fluids versus serum (see 
figure 1).  Virus concentration falling below the limit of detection of the real-time RT-
PCR as a result of degradation presents another risk of false-negative results. 
Stability of the PRRS virus in buffered media as measured by virus titration 
and quantitative PCR has been reported.  Infectivity of virus was shown to decline 
quickly as a function of time and temperature as measured by cell culture.  Under 
the conditions of this study, the authors concluded that viral RNA was stable at all 
times and temperatures evaluated24; however, the concentration of virus used was 
much higher than what is commonly seen in field samples and warrants further study 
using levels of virus more indicative of clinical samples.  Further, viral degradation in 
this study was evaluated in virus-friendly buffered media; stability would be expected 
worse in contaminated, complex sample matrices.  For this reason the conclusion of 
stability may not be directly applicable to clinical swine oral fluid samples.  
Stability of PRRS virus in the oral fluid sample matrix has been specifically 
examined.42   A pool of oral fluids collected from 16 week old finisher pigs was 
spiked with virus for a final concentration of 109 copies / ml and sampled over a 12 
hour period during which treatments with antimicrobial preservatives occurred.  
Relative to virus load in diagnostic samples (see figure 1) this concentration is 
extremely high corresponding to a Ct value of about 11 (assuming 1 copy detection 
limit at Ct of 38, with 3 Ct interval for every log of virus change).  By comparison, this 
level of PRRS virus spiked into oral fluid is 10,000,000-fold more concentrated than 
the mean field sample (Ct of 32 ~102 copies) and 109 copies of PRRS virus is 1000-
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fold higher than the highest observed field sample (Ct of 19 ~ 106 copies).  The 
conclusions of the authors were that temperature had a significant effect on virus 
stability but refrigeration of samples “will maintain integrity of PRRSV RNA for 
diagnostic testing.”42   In spite of this conclusion, mean quantity of immediately-
frozen samples were 107.8 log10 genomic copies per mL where means of refrigerated 
sampling was 107.3 log10 genomic copies per mL; a loss of 4.31x107 genomic copies 
per mL, apparently due to degradation at refrigerated temperatures.  Though not 
reported as statistically significant, this level of virus loss is troubling.  Given the fact 
that mean virus load found in oral fluid field samples average around 100 to 1000 
copies detected (estimated based on mean Ct 32 of 2381 samples tested over 12 
month period, figure 1), a loss of the published magnitude could apparently lead to a 
positive sample testing negative due to degradation during refrigeration.    
PCR Inhibition 
In addition to each of these issues impacting diagnostic sensitivity of the 
PRRS virus, inhibition of PCR presents an important hazard, particularly in swine 
oral fluid and feces.  In studies of Hepatitis A in human saliva it was noted the major 
limiting factor in amplification reactions using oral fluids are low target RNA 
concentration and the presence of inhibitory substances.3   Testing for the Epstein-
Barr virus in humans,  oral fluids were shown to ‘exert a potent inhibitory effect on 
PCR’.35  A number of studies and review papers have looked at PCR inhibition and 
provide overviews of mechanisms, targets, and sources of PCR 
inhibition.,19,29,31,48,50,57  In Bluetongue virus research among camelids, Brito notes,  
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“Unfortunately, PCR inhibitors have not been critically studied or defined in 
reality for most animal species despite the broad use of PCR in veterinary 
diagnostics.”6 
Use of an internal control (also known as a ‘mimic’ or ‘competitor RNA/DNA’) 
has been shown repeatedly to be extremely important in detection of false-negative 
reactions.27,2,8  A mimic shares the priming region of the assay’s target primers but 
contains an insert of non-native DNA or RNA.27  An exogenous internal amplification 
control consists of nucleotide sequence that is uncommon to any part of the target, 
requiring separate primers and probe for detection is a preferred method to avoid 
reporting false-negative results.8  This control is now a part of commercially available 
PRRSV RT-PCR reagent sets and has been used to detect false negatives and 
highlight increased variability associated with PCR inhibited samples.10  As the use 
of the PRRS real-time PCR test method moves from secondary confirmation of 
clinical cases to use as a tool for surveillance associated with eradication, an 
increased scrutiny on internal controls is needed.    
Sources of inhibition 
Components / molecules 
Most known inhibitors are organic, examples include:  bile salts, urea, phenol, 
ethanol, polysaccharides, humic acids, melanin, as well as different proteins such as 
haemoglobin, immunoglobin G and proteinases.   Divalent cations including calcium 
and iron are problematic as well as they interfere with the activity of magnesium in 
the PCR reaction.  Interference with fluorescent probes used in real-time PCR can 
increase background, thereby decreasing sensitivity.  Many inhibitors affect RNA 
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directly.50   An automated high-throughput filtration assay has been reported as a 
way to characterize the actual polymerase inhibitor compounds in samples, it may 
be a valuable tool for inhibitor characterization of swine oral fluid.58        
Cellular debris remaining after total nucleic acid extraction has been 
implicated in RT and PCR inhibition by altering enzyme kinetics and associated Cq 
acquisition.54  Blocking DNA from PCR priming by polysaccharides or proteins 
endogenous to the sample have been implicated.54   
Excess RNA or DNA can itself be an inhibitor, such as in flora-dense 
samples.  Swine oral fluid samples may be considered ‘flora-dense’ as previous 
work has shown high levels of bacteria present.42   Human saliva has been found to 
contain large amounts of RNA.   Human saliva was also found to contain mucins 
which may have a role in antigen capture or PCR inhibition.36   Mucin, a component 
of oral fluid, has been shown to inhibit PCR when added directly to mastermix, 
inhibiting some forms of Taq polymerase more than others.1 
Sample types 
Each host animal species and sample matrix have unique properties requiring 
separate characterization of their inhibitory properties.6  For example, human feces 
have been found to completely inhibit PCR in dilutions as high as 1:1000, potentially 
due to bile salts.30   Fecal samples are a highly variable sample matrix dependant on 
nutrition and gut flora making inhibitor characterization and generalization difficult.50   
A range of bovine sample types have been found to contain varying levels of 
contaminants affecting performance of mRNA qPCR.  Among sources evaluated, 
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tissue type (among cerebellum, liver and muscle) was noted as having the largest 
source of variance compared to influence of target gene.54 
PCR inhibitors from food samples have been noted as early as 1992.48   
Several different inhibitors have been detected in animal feed.31,50  One author has 
gone so far as to say background flora and presence of inhibitors in feed make it an 
unsuitable sample type for PCR.31  This is an important finding as feed is commonly 
found in swine oral fluid samples.  
Whole blood is known to be an inhibitor of PCR due to the heme portion of 
the red blood cell.12,50  Bone samples have been found inhibitory to PCR in forensics 
studies, making detection of low concentration target DNA difficult.16   Relatively low 
concentration of target is similar in PRRS detection from swine oral fluids (see figure 
1).  
Laboratory-derived inhibitors of PCR can include materials used in extraction 
purification such as ethanol, isopropanol, phenol, and even powder from disposable 
gloves if not appropriately controlled.50  Preservatives in plasma separation tubes 
have been found to be both inhibitory to PCR as well as a source of over-estimation 
of HIV type 1 virus.28 
Impacts of PCR inhibition  
False negative PCR due to inhibition has real impacts on veterinary 
diagnostics and the clients they serve.  In an assessment of a variety of serum 
samples (n=470) prepared from routine submissions at the University of Missouri 
VDL, partial or complete inhibition of the real-time RT-PCR was found in 20% of the 
samples where 14% were totally inhibited and 6.6% were partially inhibited.  This 
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was detected by spiking competitor RNA into extracts at a 10-fold greater 
concentration than the detection limit of the PRRS RT-PCR assay.27 
In a study of Salmonella detection in feces from human clinical cases, 8% of 
samples (n=120) were inhibited (false-negative), including two culture-positive 
samples.2   Ante-mortem diagnosis of Lawsonia in swine requires PCR testing of 
feces, although 25 of 60 fecal samples tested in one study were found to be 
inhibited.25   Several studies on the presence of Lawsonia in feces discuss low / 
intermittent shedding as a major challenge of diagnosis by fecal PCR.  After 
controlling for inhibition through the use of a mimic internal control, applicability of 
this test method may lead to different conclusions of the PCR test utility and the 
pathogenesis of the organism.25 
Avian feces are notorious for PCR inhibitors that are difficult to remove.5,13 In 
spite of using modern magnetic-bead capture extraction methods, 18% of 2668 
clinical samples studied had evidence of inhibitors that may have prevented 
detection of Avian Influenza by RT-PCR.13  Detection of Helicobacter in human feces 
has been impacted by inhibitory effects of bile, leading to discrepant research 
findings that were likely due to the presence of PCR inhibitory substances.1 
Intervention Strategies 
Processing 
Pre-treatment of specimens before nucleic acid extraction has been 
evaluated with some success.  In some cases enrichment by culture of bacteria or 
virus from a clinical sample may improve PCR sensitivity to overcome the effect of 
inhibition, although components of the enrichment media itself may prove to be 
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inhibitory if not removed.  When accompanied with extraction aimed at removal of 
inhibitors, sensitivity to Salmonella from human feces was improved to the extent 
that a nested PCR could be replaced with a single-reaction PCR.2   
Extraction 
Bustin, et al has indicated that most problems in reproducibility of RT-PCR 
stem from sample collection and purification of RNA template.8  Compounds 
inhibitory to PCR can become concentrated by the extraction method by co-
precipitation with the nucleic acids.19  Purification of sample RNA or DNA is the 
purpose of ‘extraction’ performed prior to PCR testing, but differentiating 
improvements due to reduction of inhibitory components vs. increased efficiencies of 
extraction of the actual target is not trivial.  Separating these differences has been 
noted as a confounder of a number of early comparison studies and an alternate 
statistical analysis was proposed to control for it.17   Modification of the viral lysis 
step (including more vigorous mixing and modified lysis buffer composition) has 
proven important for efficient extraction of viral nucleic acids from both swine and 
avian samples.10,13 
Use of magnetic-bead capture has proven to be a significant advancement in 
removal of a wide range of inhibitors.10,13,50  Improvements in sensitivity and removal 
of inhibitors by bead-based systems over silica-gel (spin-column) based systems 
have been noted in a number of studies.10,13,50  In some instances further 
optimization of magnetic-bead capture systems was still required to address 
unacceptable levels of false-negatives.10,13,50 
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PCR 
Appropriate design of primers has been shown to improve an assay’s ability 
to overcome or resist PCR inhibition.  Target sequences that amplify with a higher 
efficiency better resist inhibition, making documentation of PCR efficiency important 
in assay design. 7,50,54  
Use of the appropriate Taq and/or Reverse-Transcriptase enzymes have 
been found to improve resistance to inhibition.16,23  A thorough review of 
classification of types of PCR polymerases and their functionality was discussed 
elsewhere in an attempt to address PCR inhibition from bone samples.16  Briefly, 
DNA polymerases fall into distinct categories, including seven categories of which 
the most extensively utilized is Taq DNA polymerase.  The enzymatic properties 
such as nuclease activity, fidelity, extension rates, and processivity (the number of 
nucleotides added before disassociation of the enzyme) vary widely among families 
of polymerases.  Evaluation and consideration of the most appropriate polymerase 
can be a productive way to reduce or eliminate PCR inhibition. 16 
Dilution of nucleic acids prior to PCR has been shown effective as it is 
thought to increase the physical distance between the inhibitors and the target 
molecule.1   It has been described, somewhat counter intuitively, that adding more 
sample to the PCR reaction (RNA extract in this case) does not always decrease Cq 
of the reaction when inhibitors are present in the sample.  Any nucleic acid sample 
subjected to RT-PCR, PCR, or qPCR can harbor varying degrees of inhibitory 
material; therefore the practice of using one randomly chosen blanket nucleic acid 
dilution for all targets is not advisable.  For each specimen source, the ‘inhibitory 
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characteristic’, or appropriate dilution level, must first be determined.  This approach 
finds the optimum trade-off between dilution of template and dilution of inhibitors.19     
Conclusion 
PRRS real-time RT-PCR plays an important role in swine herd  control and 
elimination efforts of producers to eliminate PRRS virus from their systems.15,49  One 
metric used to measure efficacy of intervention strategies is ‘Time-To-Negative’, 
defined as the time it takes post- herd intervention to produce PRRS-negative 
groups of weaned pigs.38,39  In these types of studies, false-negative results from 
any source complicate progress and potentially undo months of work to eliminate the 
virus if positive animals are allowed to remain in the herd.38,39 
The Pork industry has continued to do battle with the PRRS virus and efforts 
are underway to control and eliminate the virus through coordinated Area Regional 
Control and Elimination projects.  Large scale PRRS control and elimination are 
estimated to cost $560 million dollars annually and may take multiple years.39   As 
this effort relies heavily on accurate detection of the PRRS virus, diagnosticians and 
veterinarians alike need to understand the limitations and assay maintenance   
required to keeps the  real-time PRRS RT-PCR methods current..  As oral fluids are 
evaluated for their role in monitoring or elimination programs, stability during 
transport needs further investigation and optimization.  Internal controls must be 
integrated into testing protocols for this sample type to ensure false-negatives 
results are prevented. False-negative PCR results, while often less frequently 
discussed than false-positives, have serious consequences when they occur. In a 
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letter to the editor of the Journal of Clinical Microbiology, a concerned diagnostician 
writes  
“It is the false-negative results that turn a risk into a threat for the population, 
whereas a false-positive result merely leads to a clarification of the 
presumptive results by retesting the sample.”22     
 
In both human and animal research there is a need for internationally 
recognized standards in reporting PCR assays to ensure adequate method 
validation7 including ring-trial validation and mandatory use of internal amplification 
controls.22 Thorough reporting of all aspects of PCR in scientific reports is lacking 
and must be improved in order to make efficient progress over time with research 
dollars.7   
It is required by ISO 17025 laboratory accreditation that each test method be 
validated for each specific sample type tested before accreditation for that 
test/sample type is granted, which reflects an underlying principle in test validation.  
In assessing the difficulties of detection of Salmonella in feed samples, Lofstrom 
wrote,  
“When optimizing PCR-based detection, the intended samples should be 
considered from the beginning because the sample itself affects the 
biochemical composition of the PCR mixture and thus the outcome of the 
analysis.”31   
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In conclusion, accurate diagnosis of the PRRS virus by real-time RT-PCR has 
continued to prove effective in the majority of cases; however a number of 
challenges are faced daily by diagnosticians and researchers.  The goals of the 
following research were to optimize and improve molecular test methods for PRRS 
detection in swine oral fluids in support of the potential this sample matrix promises 
the swine industry.   
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Abstract: The objective of the current study was to evaluate various RNA 
extraction and polymerase chain reaction (PCR) protocols for the detection of 
Porcine reproductive and respiratory syndrome virus (PRRSV) in porcine oral fluids. 
Extraction protocols were selected based on ease of use and compatibility with high-
throughput, automated systems. The results showed marked differences among 
extraction protocols, PCR protocols, and combinations thereof in detecting PRRSV 
in the oral fluid matrix. An important finding was that PCR reactions were partially 
inhibited by unknown factors in the oral fluid matrix and that inhibition was reduced 
by use of a higher concentration of PCR enzymes. The results suggest that further 
optimization of PCR assays for porcine oral fluids is needed and that laboratories 
should not assume that methods optimized for detection of virus in serum will 
perform equally with porcine oral fluids. 
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Introduction 
Oral fluid is the liquid in the buccal cavity collected by use of an absorptive 
device.2 The fluid is composed of saliva produced by the salivary glands and 
transudate that originates from the circulatory system. The diagnostic value of oral 
fluid reflects the presence of pathogens and/or antibodies produced locally or 
derived from the circulatory system. In human diagnostic medicine, both polymerase 
chain reaction (PCR)- and antibody-based assays have been modified and 
optimized for testing oral fluids for a wide variety of pathogens.11 The low cost of oral 
fluid samplings in combination with the availability of assays optimized for testing 
oral fluid specimens has made it possible to conduct large surveys for infections of 
public health importance (e.g., HIV in Africa and measles in Europe).4,5,12 
Veterinary medicine has been slow to adopt this sampling method, but testing 
of pen-based oral fluid samples has been shown to be effective for monitoring the 
circulation of Porcine reproductive and respiratory syndrome virus (PRRSV; order 
Nidovirales, family Arteriviridae, genus Arterivirus) and other infectious agents in 
populations of pigs such as Porcine circovirus-2.9,10 To date, the work has shown 
that, as in the case of human diseases, oral fluid sampling offers an efficient, cost-
effective approach for the detection of economically important infectious diseases of 
pigs.11 For porcine diagnostics, however, the process of optimizing assays for the 
oral fluid matrix and assessing their diagnostic performance has only been 
undertaken recently. Therefore, the objective of the present study was to evaluate 
nucleic acid extraction procedures and PCR protocols to identify the optimum 
combination for detection of PRRSV in oral fluid samples. 
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Materials and methods 
Experimental design 
The diagnostic performance of 5 extraction protocols and 2 reverse 
transcription (RT)-PCR protocols for PRRSV were evaluated using oral fluid samples 
from pigs of known PRRSV exposure status. Extraction protocols were selected 
based on the researchers’ familiarity with the procedures and compatibility with high-
throughput, semiautomated systems. 
The oral fluid samples used in the present study were derived from PRRSV-
inoculated pens collected up to 4 weeks postinoculation.10 Pigs were randomly 
assigned to treatment groups and then intramuscularly inoculated on day 0 with 2 ml 
of a preparation containing 1 × 101.7 50% tissue culture infective dose (TCID50) of 
PRRSV per ml. Serum samples collected 8 days before the start of the experiment 
and day 0 were assayed and determined to be negative by enzyme-linked 
immunosorbent assay (ELISA). Serum samples collected at day 10 were ELISA 
positive, confirming the presence of PRRSV infection.10 Oral fluid samples were 
collected as described elsewhere.10 A subset of oral fluid samples (n = 106), 
including 43 samples from negative control pens and 63 samples from inoculated 
pens, was selected to evaluate extraction and real-time RT-PCR protocols in the 
present study. The 63 samples from inoculated pens ranged from sampling dates 
between 1 and 4 weeks postinoculation and were selected to represent a range of 
likely PRRSV nucleic acid concentration. 
To reduce testing bias and variation, 1) oral fluid samples were completely 
randomized and blinded prior to testing; 2) extraction protocols were performed in 
30 
 
random order; 3) within each protocol, extractions on the 106 samples and 
extraction controls were performed start-to-finish in the same day; and 4) the 5 RNA 
extracts from each sample (1 for each extraction protocol) were re-arrayed to a 
single PCR plate to control for potential plate-to-plate variation in PCR master mix or 
real-time RT-PCR analysis settings between plates. Each sample was assayed 1 
time by each combination of extraction and real-time RT-PCR procedure. Results 
were statistically analyzed to determine which procedures provided the best 
diagnostic performance. 
Nucleic acid extraction protocols 
Five different nucleic acid extraction protocols were evaluated. Protocols 
differed in starting sample volume, the volume of lysate used in the extraction, final 
elution volume, and in the method of RNA capture (Table 1). 
Nucleic acid extraction protocol A1. Protocol A1 was based on a commercial 
kita and was performed according to the manufacturer’s instructions, with the 
exception of the preparation of the lysis/binding solution and the lysis step. For the 
lysis/binding solution, 40 ml of lysis/binding solution was combined with 623 μl of 
carrier RNA (without the addition of isopropanol), mixed thoroughly, and stored at 
room temperature until use. All other reagents were prepared according to the kit 
insert. For the lysis step, 175 μl of oral fluid sample was added to 235 μl of the 
lysis/binding solution in a deep-well plate.c Plates were covered with a seal,g mixed 
at 1000 rpm on an orbital plate shakerd for 5 min, and then centrifuged at 2,500 × g 
for 6 min. A volume of 115 μl of lysate was then added to each well of a new deep-
well plate to which 65 μl of isopropanolb and 20 μl of magnetic beads mix had 
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already been added. The plate was loaded onto a semiautomated nucleic acid 
purification systeme along with 2 plates of 150 μl of wash solution 1, 2 plates of 150 
μl of wash solution 2, and a final plate of 90 μl of elution buffer, as per kit 
instructions. Extraction was then completed on the semiautomated system, using 
program “AM_1836_DW50_v2.”f Thereafter, the elution plate was sealed using a 
plate sealerg and frozen at –80°C until assayed by real-time RT-PCR. 
Nucleic acid extraction protocol A2. Protocol A2 was based on a commercial 
kita and was performed according to the manufacturer’s instructions, with the 
following exceptions. Lysis/binding buffer was prepared as described in protocol A1. 
All other reagents were prepared according to the kit insert. For the lysis step, 300 μl 
of sample was added to 450 μl of prepared lysis/binding solution in a deep-well 
plate.c Plates were covered with a sealg and mixed at 1100 rpm on an orbital plate 
shakerd for 5 min, and then centrifuged at 2,500 × g for 5 min. A volume of 600 μl of 
lysate was then added to each well of a new deep-well plate to which 350 μl of 
isopropanolb and 20 μl of bead mix had already been added. The plate was loaded 
onto a semiautomated nucleic acid purification systeme along with 2 plates of 300 μl 
of wash solution 1 and 2 plates of 450 μl of wash solution 2, and a final plate of 90 μl 
of elution buffer. Extraction was then completed on the semiautomated system, 
using program “AM1836 DW 300 v2.”f Thereafter, the elution plate was sealed using 
a plate sealerg and frozen at –80°C until assayed by real-time RT-PCR. 
Nucleic acid extraction protocol A3. Protocol A3 was based on a commercial 
kith and was performed according to the manufacturer’s instructions using the 
protocol for “Disruption of Liquid Samples.” All reagents were prepared according to 
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the kit insert. In brief, 175 μl of oral fluid sample was added to 235 μl of lysis/binding 
solution in a tube containing zirconia beads for sample disruption. Bead beating was 
carried out using a high-speed shakeri for 15 min followed by centrifugation to pellet 
the beads. A volume of 115 μl of lysate was transferred to a plate containing 65 μl of 
isopropanolb and 20 μl of magnetic bead mix. The plate was loaded onto a 
semiautomated nucleic acid purification systeme along with 2 plates of 150 μl of 
wash solution 1, 2 plates of 150 μl of wash solution 2, and a final plate containing 90 
μl of elution buffer. Extraction was then completed on the semiautomated system, 
using program “AM1840 DW 50 v2.”f Thereafter, the elution plate was sealed using a 
plate sealerg and frozen at –80°C until assayed by real-time RT-PCR. 
Nucleic acid extraction protocol B1. Protocol B1 was based on a commercial 
kitj and was performed according to the manufacturer’s instructions using the 
protocol for “Cell-Free Body Fluids.” In brief, 100 μl of oral fluid sample was added to 
40 μl of proteinase Kj in a deep-well platec followed by addition of 600 μl of buffer, 
isopropanol, and magnetic bead solution (buffer RLTj). The plate was loaded onto a 
semiautomated nucleic acid purification systeme along with 2 wash plates containing 
500 μl of buffer RPE,j 1 plate containing buffer AW1,j and a final plate containing 75 
μl of elution buffer,j per kit instructions. Extraction was then completed on the 
semiautomated system, using program “KF96 Vet 100.”k Thereafter, the elution plate 
was sealed using a plate sealerg and frozen at –80°C until assayed by real-time RT-
PCR. 
Nucleic acid extraction protocol B2. Protocol B2 was based on a commercial 
kitl and was performed according to the manufacturer’s instructions. In brief, 140 μl 
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of oral fluid sample was added to 560 μl of lysis buffer in a 1.5-ml centrifuge tube, 
mixed for 15 sec by pulse vortexing, and incubated at room temperature (25°C) for 
10 min. Thereafter, 560 μl of ethanolm was added to the sample and mixed for 15 
sec by pulse vortexing. The solution was transferred to a spin columnl and was 
centrifuged at 6,000 × g. The process was repeated once with filtrate being 
discarded. Columns were then washed with 500 μl of buffer AW1,l centrifuged at 
6,000 × g, and the filtrate and collection tube discarded. Five hundred microliters of 
AW2l buffer was then added to each spin column, centrifuged at 20,000 × g, and the 
filtrate and collection tube discarded. Last, a new collection tube was attached, and 
60 μl of room temperature elution bufferl was added to each spin column. Columns 
were centrifuged at 6,000 × g for 1 min, after which collection tubes were closed and 
frozen at –80°C until assayed by real-time RT-PCR. 
Nucleic acid extraction quality control. Quality control of the extraction 
process included 1 negative control (nuclease-free water) and 2 positive controls on 
each extraction plate or run. Positive controls consisted of a PRRSV field isolate 
(ISU-P) diluted in Eagle minimum essential median to 2 levels: a “low positive” 
control (1 × 101.0 TCID50 per ml) and a “high positive” control (1 × 102.2 TCID50 per 
ml). 
PRRSV RNA amplification and detection via real-time PCR. Real-time RT-
PCR was performed with commercially available reagent sets,o in which North 
American and/or European PRRSV RNA were reverse-transcribed into 
complementary DNA and amplified by Taq DNA polymerase in a single-tube, one-
step differential real-time RT-PCR reaction. Detection of amplified target was 
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accomplished by hydrolysis probe chemistry. The master mix also contained primers 
and probes targeting an internal positive control RNA sequence.p The internal 
control RNAp was spiked into the real-time RT-PCR master mix at a concentration of 
100 copies per μl to monitor PCR amplification and allow for detection of failed PCR 
reactions. The following master mixes were evaluated. 
1× master mix. The 1× master mix was prepared according to the 
manufacturers’ instructionsf with the following component volumes per well: 12.5 μl 
of 2× RT-PCR buffer, 2.5 μl of 10× PRRSV primer probe mix, 1.25 μl of 20× 
multiplex RT-PCR enzyme mix, 0.35 μl of a solution containing 100 copies per μl of 
internal control RNA, and 0.4 μl of nuclease-free water. 
2× master mix. The 2× master mix was from the same manufacturerf but 
prepared with the following component volumes per well: 12.5 μl of 2× RT-PCR 
buffer, 2.5 μl of 10× PRRSV primer probe mix, 2.5 μl of 20× multiplex RT-PCR 
enzyme mix (double the amount in 1× master mix), and 0.35 μl of a solution 
containing 100 copies per μl of internal control RNA. 
Thereafter, the following conditions were the same for both experiments: 17 μl 
of final master mix and 8 μl of RNA extract was placed in each well of a 96-well PCR 
plate.q Real-time RT-PCR was then performed using a 96-well real-time thermal 
cyclerr using the following cycling conditions: 1 cycle at 45°C for 10 min, 1 cycle at 
95°C for 10 min, 40 cycles of 97°C for 2 sec, 60°C for 40 sec. Quality control for the 
PCR reaction included nuclease-free water as negative amplification control in 
addition to a positive amplification control provided by the manufacturer.p 
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Analysis of real-time amplification curves was performed using commercial 
thermal cycler system software.r “Auto Baseline” was used to determine 
fluorescence baselines and a “Manual Ct” threshold was set for each run, adjusted 
such that the threshold was within the linear portion of the amplification curve from 
positive amplification controls.p The threshold for internal controls was set in the 
same fashion using amplification curves from wells that contained negative 
amplification controls. Samples with threshold cycles (Cts) of <40 cycles were 
considered positive and those with Cts ≥ 40 were considered negative. 
Statistical analysis 
Analysis of the real-time RT-PCR results was performed using statistical 
software.s The Cochran Q test was used to detect significant differences in the 
proportion of PRRSV PCR positives among the 10 protocols (5 extraction protocols 
× 2 master mixes) evaluated. The protocol with the highest proportion of positives in 
oral fluid samples from PRRSV-inoculated pens of pigs was then compared pair-
wisely with the other 9 protocols using the McNemar test. Analysis of the internal 
control data was performed by the McNemar test for the qualitative 
(positive/negative) results; differences in quantitative results (Ct values) were 
analyzed using both the signed rank test on Ct differences between experiments and 
a likelihood ratio test for homogeneity of variances. 
Results 
Positive and negative extraction and amplification controls were valid for all 
extraction protocols and PCR plates. Overall, 45 out of 63 (71%) samples from pens 
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of PRRSV-challenged pigs tested positive on at least 1 protocol. Among oral fluid 
samples from negative control pens, 7 out of 430 tests (43 samples × 5 extractions × 
2 RT-PCR assays) produced positive results (Table 2), for a false-positive rate of 
1.6% (specificity = 98.4%). 
Results and statistical comparisons for all combinations of extraction and 
PCR protocols are listed in Table 2. An overall assessment of the results indicated 
significant differences in detection level among protocols (Cochran Q statistic = 
41.873, p < 0.0001). The combination of extraction A2 and the 2× master mix 
produced zero false-positive reactions in negative control oral fluid samples and the 
most positive reactions in oral fluids from PRRSV-inoculated pens. This protocol was 
significantly better (p ≤ 0.05) than 7 of the 9 other protocol combinations when the 
results from the PRRSV-inoculated pens were compared in a pair-wise fashion using 
the McNemar test. 
Using the 1× master mix in the PCR reaction, 4 of the 5 extraction methods 
had 2 or more negative control oral fluid samples in which the internal control was 
not detected (Table 3). The 2× master mix, containing twice the enzyme as the 1× 
master mix, eliminated failed internal controls in 3 of the affected protocols and 
reduced the number of failed internal controls in the fourth. The McNemar test 
calculated on the basis of a total of 11 and 4 failed internal control reactions in the 
1× and 2× master mixes, respectively, found that the difference in proportions was 
statistically significant (p = 0.0082). 
A box-and-whisker plot of Ct values for the internal control RNA in negative 
control oral fluids (n = 43) is shown in Figure 1 for every combination of extraction 
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and PCR protocols. The mean Ct value for the 1× master mix was 34.41 (95% 
confidence interval [CI]: 34.09, 34.72) and 34.79 for the 2× master mix (95% CI: 
34.69, 34.89) and were not significantly different at a p ≤ 0.05. To assess differences 
in dispersion of internal control Ct values, a likelihood ratio test for homogeneity of 
variances was performed on Ct values of internal controls and showed that the 2× 
master mix significantly reduced variation (p ≤ 0.05) for every extraction protocol. 
Discussion 
The objective of the current study was to evaluate RNA extraction and PCR 
protocols for the detection of PRRSV in porcine oral fluids. Although a relatively 
small number of procedures were tested, the results showed marked differences 
among extraction protocols, PCR protocols, and combinations thereof in the oral 
fluid matrix. Nucleic acid extractions were conducted as recommended by the 
manufacturers, but sample volumes, reagent volumes, and other factors varied 
among protocols (Table 1). This nonuniformity precluded the possibility of a detailed 
analysis of all protocol variables that could potentially impact assay performance. 
The use of an internal positive control in the PCR assay made it possible to 
determine when the reaction failed and to identify false-negative results. Each of the 
5 extraction methods produced the same or fewer failed internal control reactions 
when the concentration of PCR enzymes in the master mix was doubled. 
Simultaneously, the 2× master mix resulted in a statistically significant reduction in 
Ct variation in the internal control reactions and the same or higher rates of positivity 
in samples from PRRSV-challenged pens. Cumulatively, these results suggested 
that the PCR reaction was partially inhibited by factors in the oral fluid matrix and 
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that inhibition was reduced by use of the 2× enzyme mix, but important questions 
remain unresolved. For example, oral fluid volumes for nucleic acid extraction 
protocols A1, A2, and A3 were 175 μl, 300 μl, and 175 μl, respectively, but detection 
of PRRSV using the 1×master mix was equivalent. In contrast, the detection level for 
protocol A2 greatly improved with the 2×master mix, but detection for protocols A1 
and A3 did not. One possible explanation for this result is that the larger initial 
sample volume in protocol A2 (300 μl) eluted both more RNA and more endogenous 
inhibitors. Following this logic, doubling the concentration of PCR enzymes may 
have compensated for the greater concentration of inhibitors and allowed for 
improved RNA detection. 
Polymerase chain reaction inhibition can manifest as complete reaction failure 
(false negative) or as reduced analytical sensitivity.13 Three mechanisms of inhibition 
proposed include failure of lysis, nucleic acid degradation and capture, and 
polymerase inhibition.13 Inhibition of polymerase activity is the most common type of 
PCR inhibition.3 The presence of PCR inhibitors was previously reported in human 
oral fluids,1,7,8 and feces are known to have a similar effect.6 Because porcine oral 
fluid samples often contain some level of fecal matter and other environmental 
contaminants, inhibitors of this sample type are of particular concern. The identity 
and mechanism(s) of endogenous PCR inhibitors in swine oral fluid remain 
unknown. In human oral fluids, polysaccharides were believed to inhibit PCR; this 
inhibition was overcome with the use of a chelating resin.t,8 Other approaches to 
overcome PCR inhibition in other specimen types have been described, including 
dilution of template prior to PCR, addition of bovine serum albumin during 
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amplification, and use of PCR enzymes designed for improved resistance to 
inhibition.13 Further work is necessary to determine which of these strategies would 
be most effective. 
Testing of porcine oral fluid samples by real-time RT-PCR has been 
increasingly adopted by swine producers and veterinarians as a technique for 
monitoring the circulation of PRRSV.11 The growing use of oral fluid diagnostic 
specimens justified comparison of nucleic acid extraction and real-time RT-PCR 
protocols for the oral fluid matrix. The results of the current study clearly showed 
improvements in PRRSV PCR assay protocols for swine oral fluid, but also suggest 
that further assay optimization is needed. 
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Abstract:  Sequencing open reading frame 5 (ORF5) of the PRRS virus is a 
commonly used molecular diagnostic test for virus characterization and 
epidemiologic investigations in the United States.  Although, attempts in recent years 
to obtain PRRS virus sequencing from swine oral fluids has been less successful 
than serum, limiting the cost effectiveness of using this specimen type in disease 
eradication efforts.  It is hypothesized that polymerase-chain reaction (PCR) 
inhibition is one of many possible contributing factors reducing the efficiency of 
generating ORF5 PCR product prior to Sanger sequencing.  In this study, viral RNA 
was extracted from 156 PRRS PCR positive field samples received by the Iowa 
State University Veterinary Diagnostic Lab (ISUVDL) and tested with three different 
modifications of the PCR reaction; “regular” or standard method, “diluted” extract 
prior to PCR, and “tough” or inhibition-resistant PCR enzyme mix. Success rate of 
generating PCR product was evaluated along with concentration of amplified 
product.  For further confirmation, sequencing was attempted on a subset of 
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samples.  Target amplification was successful in 94 of the 156 (60%) samples by at 
least one method.  The ‘tough’ method proved to amplify from the most samples with 
39% detected, followed by the ‘diluted’ method with 35% detected, and finally the 
‘regular’ method with 17% detected.  The “diluted method” yielded the highest cDNA 
concentration of the target band, resulting in a significantly higher success rate of 
amplifying the target than the ‘regular’ method, and had the highest proportion of 
samples successfully sequence. 
Introduction 
PRRS virus detection by real-time PCR and subsequent sequencing of open 
reading frame (ORF) 5 are commonly requested diagnostic tests. PRRS Sequencing 
is an integral component of eradication efforts used to evaluate new virus 
introduction and monitor epidemiology of virus spread.3   In short, sequencing 
involves extraction of viral RNA from the sample matrix, followed by reverse 
transcription-polymerase chain reaction (RT-PCR) to amplify the target region of the 
virus, then purification of the amplified product, and submission to a core sequencing 
lab where Sanger sequencing is used to generate sequencing data.  Data is 
subsequently downloaded by the diagnostic lab where it is compiled and further 
characterized by comparing to other strains in dendrogram or sequence homology 
tables.   
Pen-based oral fluid samples have been shown to be effective for monitoring 
the circulation of PRRSV and other infectious agents, such as PCV2, in pig 
populations.11,12   PCR inhibitors have previously been reported in human oral fluids 
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1,8,11,17, in feces6 and animal feed7 which is important because swine oral fluids may 
contain a mix of these components due to the manner in which they are collected.12  
PCR inhibitors are of concern for their role in potential false-negative reactions or 
reduced analytical sensitivity.2,13  A previous study reports an optimized RNA 
extraction and PCR method for PRRS detection by real-time RT-PCR but that test is 
separate from the sequencing reaction.2     
While detection has been improved, subsequent virus sequencing from the 
oral fluid sample matrix has proven difficult.  A subset of PCR-positive (Ambion® 
MagMAXTM pathogen RNA/DNA kit, Life TechnologiesTM Carlsbad, CA) oral fluid 
samples submitted to the ISUVDL in 2011 was tracked for sequencing success 
rates.  Of the 1217 PRRS PCR positive oral fluid samples submitted and tested as 
previously described2, 50% (609) could not be sequenced.  In the same time period, 
1665 sera were submitted, of which only 16% (262) were unable to be sequenced 
(unpublished). The relatively low success rate of sequencing from oral fluids has 
frustrated efforts to more widely use this specimen type in eradication and other 
diagnostic efforts. A number of potentially important variables may be contributing, 
including; lower concentration of PRRS virus in oral fluid, sample degradation during 
transport, and lack of optimization of the test for this new sample type. Freezing of 
oral fluid samples has been reported to improve sequencing success rate, though 
overall success rate was still limited.15    
The goal of this study was to evaluate three RT-PCR mastermixes for their 
success in generating the initial ORF5 PCR amplicon commonly used for 
sequencing.  It is assumed that improving amplification and cDNA yield in this step 
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will improve overall success rate of PRRSV sequencing from oral fluids.  The 
correlation of initial screening PCR Ct value to success in ORF5 cDNA amplification 
across treatments was also evaluated. 
Materials and methods 
Experimental design 
The impact of three treatments on successful RT-PCR amplification of the 
ORF5 target and the yield of cDNA were evaluated as indicators of likelihood of 
overall success of PRRS Sequencing.  The method currently used by the ISUVDL 
(‘regular’) was evaluated along with two alternative RT-PCR methods (‘diluted’ and 
‘tough’).  These methods were selected based on earlier reported strategies to 
overcome PCR inhibition including inhibition-resistant enzymes, 7,14,30 and dilution of 
inhibitors prior to PCR.4,14   
Samples 
The swine oral fluid samples used were selected from clinical specimens 
submitted to the ISUVDL in 2011 with selection criteria of having an initial real-time 
PRRS PCR positive test performed as previously described.  Briefly, a large volume 
magnetic bead extraction with modified lysis buffer followed by use of a 
commercially available real-time PCR reagent set for screening of PRRSV RNA 
(Ambion® MagMAXTM pathogen RNA/DNA kit, Life TechnologiesTM Carlsbad, CA).2  
A total of 156 samples from 57 different client submissions were used in this study.  
Initial screening PRRS PCR cycle quantity (Cq) values ranged from 21 to 37 with a 
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mean Cq of 32.  Field samples as opposed to research samples were intentionally 
used in this study as a means of better representing samples received by diagnostic 
labs in contrast to spiked samples or laboratory-challenge study samples.   
Nucleic acid extraction  
Total RNA was extracted from oral fluid as previously described2 using a 
commercial extraction kit for oral fluid (Ambion® MagMAXTM pathogen RNA/DNA kit, 
Life TechnologiesTM Carlsbad, CA). The extraction was completed using an 
automated particle processor (Kingfisher-96 Magnetic Particle Processor, Thermo 
Scientific, Asheville, NC). 2   Samples were frozen after initial diagnostic testing and 
were then kept frozen at -80°Cprior to initiating the study.  All samples were 
extracted on the same day as described below and 3 equal aliquots of RNA extract 
were immediately frozen at -80°C.  After thawing, ORF5 RT-PCR was performed as 
described below.   
‘Regular’ PCR 
An aliquot of RNA extract was used as template for conventional ORF5 RT-
PCR carried according to the standard protocol used by the ISUVDL during the 2011 
period.  This PCR reaction uses qScript Custom 1-Step RT-PCR reagents from 
Quanta Biosciences (Gaithersburg, MD), mixed in the following per-reaction 
amounts:   7.2µl of RNase-free water, 12.5µl of One step MM component, 0.4µl of 
20 μM P5F2 Forward primer( 5’-AAG GTG GTA TTT GGC AAT GTG TC-3’) , 0.4 µl 
of 20 µM P5R2 Reverse primer (5’-GAG GTG ATG AAT TTC CAG GTT TCT A-3’) 
@ , and 0.5 µl qScript One-Step RT.  After mixing reagents, 21µl of this mix was 
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aliquoted into a 96-well reaction plate and 4µl of RNA extract was added from each 
sample.  Thermal cycling conditions were one hold of 48°C 20 min, one hold  of 
94°C 3 min, 45 cycles: 94°C 30 sec, 50°C 50 sec, 68°C 50 sec, and one hold of  
68°C 7 min, followed by 4°C hold.  The same primer sequences, which are expected 
to produce a 1082 base-pair (bp) band, were used for all three PCR treatments.  
‘Diluted’ RNA Extract PCR 
Based on earlier work by Gallup4 the “inhibitory characteristic” of the study 
samples was evaluated to arrive at the optimal dilution of RNA extract to use for 
subsequent PCR.  This approach seeks the optimal intersection of inhibitor and 
target dilutions.  Sixteen samples were randomly chosen from the 156 total samples 
using one sample only from a given accession.  Loosely following the methodology 
of the “P-Q program”™ described by Gallup elsewhere4, serial dilutions of extract 
were used as template for the ‘regular’ ORF5 PCR method described above.  RNA 
extract was diluted in PCR-grade water in the following six dilutions: undiluted, 1:2, 
1:4, 1:8, 1:16, and 1:32.  DNA concentration of the resulting PCR product was 
measured using the QIAxcel capillary electrophoresis system (Qiagen, Valencia CA) 
and the consensus of ‘best’ dilution among all 16 samples was chosen.  An example 
of results of the dilution series from one of the 16 samples is shown in Diagram 1 
below.  The dilution that had the highest DNA yield on average of the 16 samples 
was used hereafter.  Dilution of all RNA extracts at this level (1:2 in Molecular-grade 
water) prior to PCR constituted the ‘diluted’ method with all other componentsequal 
to the ‘regular’ method described earlier.    
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‘Tough’ mastermix PRRS PCR 
An alternate set of PCR reagents containing inhibition-resistant enzyme mix 
was used for the ‘tough’ treatment.  Reagents were qScript XLT One-Step RT-PCR 
kit from Quanta Biosciences (Gaithersburg, MD).  All reaction volumes were the 
same as the ‘regular’ PCR method described earlier but with the substitution “Tough-
mix” RT-PCR reagents from Quanta Biosciences (Gaithersburg, MD). 
Electrophoresis 
Amplified DNA detection and quantification was carried out using a QIAxcel 
capillary electrophoresis instrument and associated ScreenGel software per 
manufacturer instructions.13   The DNA Screening kit was used along with QX 
Alignment Marker 15bp / 3kb and a FX174 / Hae III ladder.  Sample PCR product 
was diluted 1:5 and the ladder diluted 1:3.33 in DNAse free molecular grade water 
per instructions.13 The DNA ladder had a final concentration of 30ng/µl and served 
both as size detection and quantification standard.   Run parameters were:  Method 
AM420, 5kV Injection and Separation Voltage, 8.5 Acquisition Rate [Hz], 0.3 sec 
Rise Time, 10 sec Injection Time, and 425 sec separation time.  For analysis, 0.25 
sec minimum separation 3.38% positive threshold and 40 sec Baseline Filter 
window. 
After initial analysis, samples were re-analyzed such that all treatments of the 
same sample were examined for size and concentration together in one analysis run 
of the software to limit any between-run variation present in the system. QIAxcel 
ScreenGel™ software was used to detect, determine size, and quantify relative 
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concentration of products.  DNA concentration reported was reported in units of as-
found ng/µl and do not account for sample dilution as only relative differences 
among treatments were of interest. 
A single band closest to the target size of 1080bp was selected when multiple 
bands for a given sample were observed.  Bands within 20% of the target size (900-
1300bp) detected during analysis were considered “positive” based on stated 
inaccuracy limits of the method used.13   The assumption that a fragment in this size 
range would generate a successful sequence was tested on a subset of 47 samples 
which were selected from a range of product sizes within each treatment.  These 
were submitted to a DNA core facility for sequencing, compiled and confirmed as 
PRRS virus by aligning with VR-2332 PRRS using Lasergene sequence alignment 
software (DNA Star, Madison, Wisconsin).   
Statistical Analysis 
Significance of the number of ORF5 PCR positive samples was first 
evaluated using Cochran’s test for detecting differences among all treatments, 
followed by pair-wise McNemar’s test for each combination.  Differences in cDNA 
yield among treatments were first evaluated using Cochran’s Mantel-Hanzel test 
followed by pair-wise Wilcoxon signed-rank test for each combination.   
Lastly, the correlation of initial screening real-time RT-PCR Cq value to 
likelihood of generating the target-sized ORF5 PCR product was evaluated among 
the three treatments.   A mixed-effect logistic regression model was created with 
treatment, Cq, and their interaction as fixed effects and sample number as the 
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random effect.  This was an effort to see if any of the methods improved this 
correlation.  Cq values are often used by submitting veterinarians to choose the 
sample with the most virus within an accession for sequencing, however an 
unpredictable success rate of sequencing has been observed with oral fluids.  
Statistical analyses were performed using SAS® Version 9.2 (SAS® Institute Inc., 
Cary, NC, USA). 
Results 
Optimal dilution for “Diluted” treatment 
RNA extract from 16 samples were each tested using the ‘regular’ ORF5 RT-
PCR method to find the optimal dilution which minimized impact of PCR inhibitors as 
described above.  cDNA concentration of the band in the 900-1300bp range closest 
to 1080bp were evaluated and the strongest concentration chosen for each sample.  
In total 12 of the 16 samples successfully amplified in at least one of the dilutions; 
four samples did not amplify at any dilution.  Results of the dilutions yielding the 
highest PCR product concentration were follows:  two samples were best undiluted, 
nine samples were best diluted 1:2, one sample was best diluted 1:16, and no 
samples had highest concentration at the 1:4 or 1:32 dilution.  A 1:2 dilution was 
then used as the single dilution of RNA extract for the 156 study samples in the 
‘diluted’ treatment.  
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ORF5 RT-PCR Results 
RT-PCR cDNA amplification of a band in the described range was successful 
in 94 of the 156 (60%) samples by at least one method with eight samples detected 
by all three methods, 33 detected by two methods and 53 detected by only one 
method.  The ‘tough’ method proved to amplify the most samples with 62 detected, 
followed by the ‘diluted’ method with 55 detected, and finally the ‘regular’ method 
with 26 detected.  A Cochran’s Q test p<0.0001 result was found indicating 
differences among treatment groups.  Pair-wise McNemar’s test on number detected 
was performed for each treatment pair, results were as follows:    regular vs. diluted 
p<0.0001, regular vs. tough p<0.0001, diluted vs. tough p = 0.3778.  Pair-wise 
testing using McNemar’s test revealed significantly improved detection for ‘Tough’ 
and ‘Diluted’ treatments compared to ‘Regular’, however no significant difference 
between ‘Diluted’ and ‘Tough’.  It was noted that ‘Tough’ generated a greater 
number of cDNA fragments smaller than the target size compared to ‘Regular’ and 
‘Diluted’ which may have impacted its performance. 
ORF5 cDNA from a subset of 47 of the 94 successfully amplified PCR 
products was submitted to a DNA core facility to verify that successful amplification 
of the ORF5 target is indicative of successful sequencing.  The subset included 14 
‘regular’, 12 ‘diluted’ and 21 ‘tough’ samples.  Overall 23 (49%) of these samples 
produced a sequence that was then compared to known VR-2332 sequence and 
positively identified as PRRSV, and 24 did not generate useable sequence data that 
could be compiled.  By treatment, 10 of 14  of ‘Regular’, 8 of 12 of ‘Diluted’, and 5 of 
21 of ‘Tough’ were successful through the full sequencing process.  Using these 
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success rates multiplied by the total number detected for each treatment, 19 (26 x 
71%), 37 (55 x 67%), and 15 (62 x 24%) samples would be predicted to successfully 
sequence among ‘regular’, ‘diluted’, and ‘tough’ treatments respectively.  Results of 
ORF5 RT-PCR success and predicted total number of successful sequences are 
shown in table 1 below by treatment. 
The highest cDNA concentration of the single dominant band from each 
positive sample on average resulted from the diluted treatment with the lowest 
average concentration in the tough treatment.  Comparison of cDNA concentration 
by treatment is shown in table 2 below.  For cDNA concentration or yield Cochran’s 
Mantel-Hanzel test detected significant differences among treatments.  Pair-wise 
Wilcoxon signed-rank tests indicated significantly lower DNA yield for ‘tough’ 
treatment compared to ‘regular’ or ‘diluted’ and significantly higher concentration for 
‘diluted’ treatment compared to ‘regular’ or ‘tough’ at p≤0.05.   
Linear regression modeling demonstrated that Ct was a statistically significant 
predictor of generating ORF5 PCR product in ‘diluted’ and ‘regular’ but not in ‘tough’ 
treatments at p≤0.05 see table 3 below. 
Discussion 
A number of factors not tested in this study may account for unsuccessful 
sequencing from field samples.  Successful amplification from field samples may 
have been hindered by viral RNA sequences that differed from primers used for the 
PCR and sequencing.  The PRRS virus has the highest known mutation rate of RNA 
viruses9 which often leads to failure of primers to anneal.5   Further, primer design 
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has been shown to be an important aspect of a PCR assay’s ability to overcome 
PCR inhibition.16   In this study, a single primer set was used and follow-up with 
alternate ORF5 primer sets was not attempted but in practice alternate primer sets 
may be implemented when initial detection is unsuccessful.      
The extraction method used in this study uses magnetic silica beads which 
have been previously shown to be effective in removal of PCR inhibitors from a 
number of specimen types.14,17,27   Other modifications to this extraction platform  
that may also be useful but were not attempted here have been found effective with 
other sample types, including high-salt wash lysis buffer and additional or modified 
wash solutions.27,29   
A significant improvement in amplification of target DNA was found with use 
of either ‘tough’ mastermix or dilution of extract 1:2 prior to PCR.  Both inhibition-
resistant polymerases7,14,17,30 and dilution of inhibitors4,14,17 have previously been 
shown to improve amplification efficiency, which is consistent with the results of this 
study and indicate that such strategies may improve sequencing success rates.  
Further work should be done to evaluate the variety of inhibition-resistant RT and 
DNA polymerases commercially available as only one vendor and product was 
evaluated in this study and there may be other alternatives that better suit swine oral 
fluids. 7,30   The higher number of cDNA fragments smaller than the target size 
suggests that this assay may have benefited from optimizing the annealing 
temperature to improve reaction specificity.  Finally, a combination of treatments by 
diluting nucleic acid extract in addition to use of inhibition-resistant polymerases is 
worth exploring further. 
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Using real-time PRRS RT-PCR Cq values as a predictor of successful 
sequencing is common practice with serum samples.  In the presence of inhibitors, 
however, Ct values are no longer reliable indicators of virus quantity.4  Of the three 
treatments evaluated, ‘diluted’ produced the lowest p-value of p = 0.0002 in the 
logistic regression modeled.  This supports findings of Gallup who proposed the 
‘CRUD rule’ as “Cq values are only Reliable in Uninhibited qPCR reactions where 
samples have undergone premeditatedly precise Dilutions.”4 
Dilution of RNA extract is fairly simple to implement and resulted in a 
significantly better success in amplifying the target compared to the “tough” 
treatment.  Though not significant, dilution of the template yielded slightly higher 
DNA concentration than the ‘tough’ enzyme evaluated, and had a higher proportion 
of samples successfully sequenced.  The dilution rate used in this study was the 
consensus of only a subset of 16 of the 156 samples within the study, each 
diagnostic specimen or source can be assumed to ideally require a different 
dilution.4   For diagnostic labs, optimizing with a larger sample set may be worthwhile 
before selecting a standard dilution.    
The assumption that poor success of sequencing PRRS virus from oral fluid 
was mainly a function of failed ORF5 PCR was somewhat refuted by the relatively 
low rate of generating a final compilable sequence.   This suggests that other factors 
besides inhibition, such as virus degradation or inhibition of other aspects of Sanger 
sequencing may be at play.  It is also possible that the range for “positive” band size 
was too wide, though it was selected based on stated inaccuracy limits of the 
instrument used.13 
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In conclusion, improvement of success rate in PRRS Sequencing was found 
possible through dilution of RNA extract prior to RT-PCR but more work is needed in 
order to achieve the level of success achievable from serum samples. 
 
Figure 1 – Example of selection of “Best Dilution” of RNA extract to maximize 
PCR DNA yield 
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Table 1 – Percent of oral fluids ‘positive’ by ORF5 RT-PCR and estimated 
sequencing success rate 
 
Table 2:  cDNA concentration by treatment of single band per sample 
 
Treatment
ORF5 DNA Fragment 
Detected 
(900‐1300bp) 
Estimated Sequencing 
Success Rate*
16.67% A
(26/156)
35.26% B
(55/156)
39.74% B
(62/156)
Cochran's Q test detected differences of ORF5 DNA detected among all treatments p<0.0001
AB  frequencies significantly different by McNemar’s test at p<0.0001
‘Regular’ Mastermix
‘Diluted’ Extract 1:2 with 
Regular Mastermix
‘Tough’ Mastermix 9.6%
23.7%
12.2%
*Subset of each treatment attempted for full sequencing.     Estimated success rate = 
((number sequence success / number attempted) x number ORF5 DNA detected) / 156 
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Table 3:  Cq as predictor of successful ORF5 RT-PCR by treatment 
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CHAPTER 4.  GENERAL CONCLUSIONS 
 
General Conclusions and Future Directions 
 
Diagnosis of PRRS virus by the latest molecular test methods may pose the 
biggest challenge to swine diagnostic laboratories.  The work reported here lead to 
modest improvements in sensitivity and success rates of real-time RT-PCR and 
virus sequencing respectively.  It is now clear that PCR inhibition is an important 
obstacle with this sample matrix. 
PRRS viral RNA in swine oral fluids faces serious threat of degradation by 
consumption from contaminant bacteria, salivary enzymes, pH increases associated 
with bacterial growth, and likely large concentrations of nucleases capable of 
destroying RNA once outside the nucleocapsid.  Although some work has been 
reported in this area, repeating this work is justified based on relatively low virus load 
in oral fluid alone.   
Finally, although this work focused on laboratory methods to overcome ‘dirty’ 
field samples; cleaner on-farm collection of swine oral fluids has potential to improve 
the final diagnostic result.  Any progress on the methodology to collect a purer 
sample makes efforts of lab methods more effective and should be pursued.  
 
 
 
